An international gathering of mesothelioma experts will take place in California in a few weeks, bringing together physicians and other healthcare professionals, as well as advocates, patients, their families and caregivers. The event is the 9thAnnual International Symposium on Malignant Pleural Mesothelioma, and it will take place on September 21stat the Meyer & Renee Luskin Conference Center at the UCLA campus. The symposium is being hosted by both The Pacific Mesothelioma Center and UCLA.
Malignant pleural mesothelioma is a rare form of cancer that is caused by exposure to asbestos. It affects the lining of the chest cavity, and is always considered a fatal disease. Patients do not begin to show symptoms of their illness until several decades after their exposure to the carcinogenic material, and most succumb to the condition within two years of diagnosis. Mesothelioma can also form in the abdominal cavity, in which case it is called malignant peritoneal mesothelioma.
The goal of the mesothelioma symposium is to provide the opportunity for physicians to share the most up-to-date information on treatment protocols and other issues of interest with colleagues, medical students, nurses, patients, family members, and others involved in the care and treatment of mesothelioma patients. Continued medical education (CME) credit opportunities will also be offered.
Some of the topics that will be covered at this year’s symposium include:
- Surgery updates
- Oncology updates
- Car T-Cell therapy
- Tumor Treating Fields
- Long-term outcomes of multi-modality therapy
- Immunological environments in mesothelioma tumors
- Development of mesothelioma immunotherapy by controlling immunosuppressive tumor environment
- Mesothelioma tumor regression via a novel microRNA-based logoregional therapy
- Molecular heterogeneity in mesothelioma
Among the featured speakers at this year’s symposium will be Robert B. Cameron, MD,
FACS, Director of the UCLA Mesothelioma Comprehensive Research Program and Senior Professor at UCLA. Others include Prasad S. Adusumilli, MD, FACS FCCP of Weill Cornell Medical Center, NY; Giovanni Luca Ceresoli, MD of Thoracic and GU Oncology Unit, Bergamo Italy; Chuong D. Hoang, MD, FACS of NIH, Bethesda, Maryland, and many from UCLA.
As medical experts continue to work in their fight against mesothelioma, we are seeking justice on behalf of victims of asbestos exposure. For information on how we can help you, contact us at 1-800-966-2244.